Concepedia

Alberto Bessudo

AB

Statistics

Publications

33

Citations

1.5K

H-Index

20

Active since

1995

Affiliations

California Cancer Associates for Research and Excellence(Current)

Institute for Myeloma & Bone Cancer Research

The University of Texas MD Anderson Cancer Center

Sarah Cannon

Oncotherapeutics (United States)

Alberto Bessudo is an author at California Cancer Associates for Research and Excellence specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1995–2023

33

Publications

33

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

Jonathan W. Friedberg, Philip Cohen, Ling Chen et al. · Journal of Clinical Oncology · 2008 · 298 citations · Full text

Denosumab for Treatment of Hypercalcemia of Malignancy

Mimi I. Hu, Ilya Glezerman, Sophie Leboulleux et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 196 citations · Full text

CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma

James R. Berenson, Alan Cartmell, Alberto Bessudo et al. · Blood · 2016 · 94 citations · Full text

Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses

Charles H. Redfern, Troy H. Guthrie, Alberto Bessudo et al. · Journal of Clinical Oncology · 2006 · 88 citations

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single‐arm study

James R. Berenson, Ralph V. Boccia, David S. Siegel et al. · British Journal of Haematology · 2006 · 81 citations

, , +14

1–5 of 33